<code id='DA9A9AC03C'></code><style id='DA9A9AC03C'></style>
    • <acronym id='DA9A9AC03C'></acronym>
      <center id='DA9A9AC03C'><center id='DA9A9AC03C'><tfoot id='DA9A9AC03C'></tfoot></center><abbr id='DA9A9AC03C'><dir id='DA9A9AC03C'><tfoot id='DA9A9AC03C'></tfoot><noframes id='DA9A9AC03C'>

    • <optgroup id='DA9A9AC03C'><strike id='DA9A9AC03C'><sup id='DA9A9AC03C'></sup></strike><code id='DA9A9AC03C'></code></optgroup>
        1. <b id='DA9A9AC03C'><label id='DA9A9AC03C'><select id='DA9A9AC03C'><dt id='DA9A9AC03C'><span id='DA9A9AC03C'></span></dt></select></label></b><u id='DA9A9AC03C'></u>
          <i id='DA9A9AC03C'><strike id='DA9A9AC03C'><tt id='DA9A9AC03C'><pre id='DA9A9AC03C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:33
          AdventHealth alleges in a new lawsuit that MultiPlan conspires with health insurers to keep out-of-network payments low. Adobe

          AdventHealth, a large religious-affiliated hospital system, has sued MultiPlan, alleging the company has worked with health insurers to create a “cartel” that systematically underpays hospitals and doctors for care that is delivered out of an insurance company’s network.

          AdventHealth claims it has “overwhelming direct evidence” that MultiPlan’s agreements with health insurance companies are anticompetitive, and that MultiPlan’s “multi-year, ongoing conspiracy” with insurers has shortchanged hospitals and doctors at least $19 billion per year. MultiPlan said in a statement it “believes this lawsuit has no merit and looks forward to disproving these baseless allegations.”

          advertisement

          The lawsuit pours fresh gasoline on the fraught relationships between hospitals and insurance companies. It also adds to the ongoing debate about how much providers should be paid if they don’t agree to be part of an insurance network.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Why Charlie Gard's case is so disturbing to Americans
          Why Charlie Gard's case is so disturbing to Americans

          ConnieYates,motherofterminallyillbabyCharlieGard,carriesastuffedanimalafterdeliveringapetitionofsign

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Copay coupons to count toward deductibles, after Biden court move

          AdobeWASHINGTON—Insurerswillhavetocountdrugcopaycouponstowarddeductiblesandpatientspendingcapsinmost